Go Pro

Inspire Veterinary Partners (IVP) Competitors

Inspire Veterinary Partners logo
$0.03 0.00 (0.00%)
As of 09/11/2026

IVP vs. AGRZ, MLEC, EDBL, ORIS, and YTEN

Should you buy Inspire Veterinary Partners stock or one of its competitors? Inspire Veterinary Partners's main competitors and comparable companies include AGRZ (AGRZ), Moolec Science (MLEC), Edible Garden (EDBL), Oriental Rise (ORIS), and Yield10 Bioscience (YTEN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "agricultural products & services" industry.

How does Inspire Veterinary Partners compare to AGRZ?

AGRZ (NASDAQ:AGRZ) and Inspire Veterinary Partners (NASDAQ:IVP) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

AGRZ has higher earnings, but lower revenue than Inspire Veterinary Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AGRZ$9.14M0.57$790KN/AN/A
Inspire Veterinary Partners$15.56M0.09-$14.26M-$2.20N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AGRZ
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inspire Veterinary Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

4.8% of Inspire Veterinary Partners shares are owned by institutional investors. 6.4% of Inspire Veterinary Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

AGRZ has a net margin of 0.00% compared to Inspire Veterinary Partners' net margin of -76.75%. AGRZ's return on equity of 0.00% beat Inspire Veterinary Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
AGRZN/A N/A N/A
Inspire Veterinary Partners -76.75%-520.34%-55.79%

In the previous week, AGRZ had 4 more articles in the media than Inspire Veterinary Partners. MarketBeat recorded 4 mentions for AGRZ and 0 mentions for Inspire Veterinary Partners. AGRZ's average media sentiment score of 0.29 beat Inspire Veterinary Partners' score of 0.00 indicating that AGRZ is being referred to more favorably in the media.

Company Overall Sentiment
AGRZ Neutral
Inspire Veterinary Partners Neutral

Summary

AGRZ beats Inspire Veterinary Partners on 7 of the 10 factors compared between the two stocks.

How does Inspire Veterinary Partners compare to Moolec Science?

Inspire Veterinary Partners (NASDAQ:IVP) and Moolec Science (NASDAQ:MLEC) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

Inspire Veterinary Partners has higher earnings, but lower revenue than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Inspire Veterinary Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Veterinary Partners$15.56M0.09-$14.26M-$2.20N/A
Moolec Science$333.61M0.02-$111.46M-$33.00N/A

Inspire Veterinary Partners has a beta of -0.49, meaning that its stock price is 149% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.26, meaning that its stock price is 74% less volatile than the broader market.

4.8% of Inspire Veterinary Partners shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 6.4% of Inspire Veterinary Partners shares are held by insiders. Comparatively, 19.9% of Moolec Science shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Moolec Science had 2 more articles in the media than Inspire Veterinary Partners. MarketBeat recorded 2 mentions for Moolec Science and 0 mentions for Inspire Veterinary Partners. Moolec Science's average media sentiment score of 1.43 beat Inspire Veterinary Partners' score of 0.00 indicating that Moolec Science is being referred to more favorably in the news media.

Company Overall Sentiment
Inspire Veterinary Partners Neutral
Moolec Science Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Veterinary Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Moolec Science
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Moolec Science has a net margin of 0.00% compared to Inspire Veterinary Partners' net margin of -76.75%. Moolec Science's return on equity of 0.00% beat Inspire Veterinary Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Veterinary Partners-76.75% -520.34% -55.79%
Moolec Science N/A N/A N/A

Summary

Moolec Science beats Inspire Veterinary Partners on 8 of the 14 factors compared between the two stocks.

How does Inspire Veterinary Partners compare to Edible Garden?

Edible Garden (NASDAQ:EDBL) and Inspire Veterinary Partners (NASDAQ:IVP) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

Edible Garden has a beta of 1.75, suggesting that its share price is 75% more volatile than the broader market. Comparatively, Inspire Veterinary Partners has a beta of -0.49, suggesting that its share price is 149% less volatile than the broader market.

Inspire Veterinary Partners has higher revenue and earnings than Edible Garden. Inspire Veterinary Partners is trading at a lower price-to-earnings ratio than Edible Garden, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edible Garden$12.81M0.16-$17.33M-$1.99 thousandN/A
Inspire Veterinary Partners$15.56M0.09-$14.26M-$2.20N/A

In the previous week, Edible Garden had 5 more articles in the media than Inspire Veterinary Partners. MarketBeat recorded 5 mentions for Edible Garden and 0 mentions for Inspire Veterinary Partners. Edible Garden's average media sentiment score of 1.10 beat Inspire Veterinary Partners' score of 0.00 indicating that Edible Garden is being referred to more favorably in the media.

Company Overall Sentiment
Edible Garden Positive
Inspire Veterinary Partners Neutral

Inspire Veterinary Partners has a net margin of -76.75% compared to Edible Garden's net margin of -122.09%. Edible Garden's return on equity of 0.00% beat Inspire Veterinary Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Edible Garden-122.09% N/A -78.65%
Inspire Veterinary Partners -76.75%-520.34%-55.79%

13.0% of Edible Garden shares are owned by institutional investors. Comparatively, 4.8% of Inspire Veterinary Partners shares are owned by institutional investors. 0.8% of Edible Garden shares are owned by insiders. Comparatively, 6.4% of Inspire Veterinary Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Edible Garden presently has a consensus target price of $45.00, suggesting a potential upside of 2,982.19%. Given Edible Garden's stronger consensus rating and higher possible upside, research analysts plainly believe Edible Garden is more favorable than Inspire Veterinary Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edible Garden
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inspire Veterinary Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Edible Garden beats Inspire Veterinary Partners on 10 of the 16 factors compared between the two stocks.

How does Inspire Veterinary Partners compare to Oriental Rise?

Oriental Rise (NASDAQ:ORIS) and Inspire Veterinary Partners (NASDAQ:IVP) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

Oriental Rise has a beta of 1.54, suggesting that its share price is 54% more volatile than the broader market. Comparatively, Inspire Veterinary Partners has a beta of -0.49, suggesting that its share price is 149% less volatile than the broader market.

Oriental Rise has higher earnings, but lower revenue than Inspire Veterinary Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oriental Rise$12.22M0.04$680KN/AN/A
Inspire Veterinary Partners$15.56M0.09-$14.26M-$2.20N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oriental Rise
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inspire Veterinary Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Oriental Rise's average media sentiment score of 0.00 equaled Inspire Veterinary Partners'average media sentiment score.

Company Overall Sentiment
Oriental Rise Neutral
Inspire Veterinary Partners Neutral

4.8% of Inspire Veterinary Partners shares are owned by institutional investors. 6.4% of Inspire Veterinary Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Oriental Rise has a net margin of 0.00% compared to Inspire Veterinary Partners' net margin of -76.75%. Oriental Rise's return on equity of 0.00% beat Inspire Veterinary Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Oriental RiseN/A N/A N/A
Inspire Veterinary Partners -76.75%-520.34%-55.79%

Summary

Oriental Rise beats Inspire Veterinary Partners on 5 of the 9 factors compared between the two stocks.

How does Inspire Veterinary Partners compare to Yield10 Bioscience?

Yield10 Bioscience (NASDAQ:YTEN) and Inspire Veterinary Partners (NASDAQ:IVP) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Yield10 Bioscience has a net margin of 0.00% compared to Inspire Veterinary Partners' net margin of -76.75%. Yield10 Bioscience's return on equity of 0.00% beat Inspire Veterinary Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Yield10 BioscienceN/A N/A -296.08%
Inspire Veterinary Partners -76.75%-520.34%-55.79%

Yield10 Bioscience has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Inspire Veterinary Partners has a beta of -0.49, suggesting that its stock price is 149% less volatile than the broader market.

4.9% of Yield10 Bioscience shares are owned by institutional investors. Comparatively, 4.8% of Inspire Veterinary Partners shares are owned by institutional investors. 6.1% of Yield10 Bioscience shares are owned by company insiders. Comparatively, 6.4% of Inspire Veterinary Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Given Yield10 Bioscience's higher probable upside, equities analysts plainly believe Yield10 Bioscience is more favorable than Inspire Veterinary Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yield10 Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Inspire Veterinary Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspire Veterinary Partners has higher revenue and earnings than Yield10 Bioscience. Inspire Veterinary Partners is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A
Inspire Veterinary Partners$15.56M0.09-$14.26M-$2.20N/A

In the previous week, Yield10 Bioscience had 1 more articles in the media than Inspire Veterinary Partners. MarketBeat recorded 1 mentions for Yield10 Bioscience and 0 mentions for Inspire Veterinary Partners. Yield10 Bioscience's average media sentiment score of 0.00 equaled Inspire Veterinary Partners'average media sentiment score.

Company Overall Sentiment
Yield10 Bioscience Neutral
Inspire Veterinary Partners Neutral

Summary

Yield10 Bioscience beats Inspire Veterinary Partners on 7 of the 13 factors compared between the two stocks.

Get Inspire Veterinary Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for IVP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IVP vs. The Competition

MetricInspire Veterinary PartnersFood Products IndustryConsumer Staples SectorNASDAQ Exchange
Market Cap$1.41M$5.58B$15.57B$12.85B
Dividend YieldN/A3.17%3.26%11.71%
P/E Ratio-0.0213.7014.0625.36
Price / Sales0.0983.68262,948.66111.77
Price / CashN/A113.0856.8751.52
Price / Book0.033.764.766.20
Net Income-$14.26M$770.76M$837.55M$358.50M
7 Day PerformanceN/A-1.06%-1.42%-2.35%
1 Month PerformanceN/A-0.78%-1.79%-3.23%
1 Year PerformanceN/A38.19%10.48%8.79%

Inspire Veterinary Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IVP
Inspire Veterinary Partners
N/A$0.03
flat
N/AN/A$1.41M$15.56MN/A156
AGRZ
AGRZ
N/A$0.25
+11.7%
N/AN/A$5.46M$62.68MN/AN/A
MLEC
Moolec Science
1.1308 of 5 stars
$6.77
-2.4%
N/A-66.0%$4.96M$338.84MN/A4
EDBL
Edible Garden
3.058 of 5 stars
$1.41
-0.8%
$45.00
+3,093.8%
-99.8%$1.94M$13.84MN/A50
ORIS
Oriental Rise
N/A$1.83
flat
N/AN/A$503K$12.22MN/AN/A

Related Companies and Tools


This page (NASDAQ:IVP) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners